The abstract is read at the publisher; the summary is JClub's.
Nearly 35% of 23,840 eMERGE participants (ages 3–75) received high-risk genome-informed risk assessments, most often driven by family history and high PRS.
- Why it matters: Returning genome-informed risk results is critical for precision medicine, but large-scale feasibility and drivers of high-risk delivery—and who may be left out—remain unclear.
- What they did: eMERGE assessed risk for 11 common conditions using PRSs, monogenic variants, and family history, placed results in electronic health records, and attempted 1:1 returns for high-risk PRS/monogenic/BOADICEA results.
- The result: Among 4,911 eligible for 1:1 return, completion rates were 78.5% for adults and 67.5% for children; inability to contact participants was the main barrier, and homeownership, “good health,” highest education, and lack of health insurance were significantly associated with successful 1:1 return.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.